about
The mUBC9 murine ubiquitin conjugating enzyme interacts with the E2A transcription factorsMutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell diseaseGenetic determinants of haemolysis in sickle cell anaemia.Strategic plan for pediatric respiratory diseases research: an NHLBI working group report.Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive painProteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell diseaseApolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell diseaseSegmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension.Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease.Risk factors for death in 632 patients with sickle cell disease in the United States and United KingdomElevated sphingosine-1-phosphate promotes sickling and sickle cell disease progressionHigh levels of placenta growth factor in sickle cell disease promote pulmonary hypertensionAssociation of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in AfricaHeme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factorHydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemiaEndogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and deathA retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institutionImaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease.A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease.Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.Effect of extended-release niacin on serum lipids and on endothelial function in adults with sickle cell anemia and low high-density lipoprotein cholesterol levels.Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell diseaseSildenafil therapy in patients with sickle cell disease and pulmonary hypertension.Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia.Sleep disturbance, depression and pain in adults with sickle cell disease.Hemolysis-associated pulmonary hypertension in thalassemia.Characterizing non-linear dependencies among pairs of clinical variables and imaging data.Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease.Imaging flow cytometry for morphologic and phenotypic characterization of rare circulating endothelial cells.Expression of regulatory platelet microRNAs in patients with sickle cell diseaseThe proteome of sickle cell disease: insights from exploratory proteomic profiling.A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia.Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsSevere painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study.
P50
Q24316101-72A37FE9-AB21-4C72-90AA-2A3CE0D1302FQ24606163-BA17FC34-C086-470A-BE6D-72063A9EB812Q29417116-2A49548B-266F-4BAB-95F7-E9FD065F5817Q30485294-FA2FD574-BE50-49C0-96A9-AE377B9EB55EQ30833776-C769EDAD-A0C0-492C-B57C-5FA089E2FE75Q30945205-6371055B-C4DA-4EE8-B87C-0B4AFA167587Q33332124-B7E2D471-2C9F-4961-A4EE-68DD57D08381Q33385956-90D97C06-7C99-4FA1-93AF-55231D04C678Q33551127-0B98845A-404E-42EE-AF13-AB5CF0DB50C4Q33766843-0A04AE5B-6282-4AD3-AD17-A3CC366EA37EQ33805998-1E340B88-CD56-4F56-94DE-A46F721973DDQ33837174-77031DED-E12F-4FA3-958E-259B5D855015Q33872564-3B246792-58C2-46E5-B947-ACFF99849DEFQ33997180-86E56712-1DC6-49F7-AA7F-0B89971AC4ACQ34005594-2DE9890C-9E04-4796-8C50-41A8CEFA7023Q34009129-D1EE7D20-A391-4881-ABE5-2729DEAA8EEBQ34019609-783B828D-FA5F-4C78-B561-5288D92C3245Q34110079-2A57A948-0021-4562-BB41-A4838250A14AQ34111548-4D48977C-9A32-462A-9647-00AAA011FC40Q34155329-160C7636-C6DC-4DAD-A6A3-1F5B11FAD8CFQ34266987-9EE3A29B-DAC6-4D3D-B562-46C82CD70FC8Q34322438-7F4D7E89-BE46-4469-AA93-5D2E82B65E69Q34330046-A6C977F1-82A6-4C2B-AE32-19F004EDC3AFQ34337258-DC913230-F021-4227-B559-55DB2DBDECCEQ34431518-8E5F04AD-36A3-45C2-8325-F689D248EA55Q34436782-6EC7A2FB-82D8-458C-B0A3-58AE9208EB77Q34451512-77E40DF5-FE7E-43B2-A687-1E9CDA0F29B5Q34469224-5A2B51DC-6BAB-439E-9C3F-F346320FA6E8Q34474615-45E8A339-9E7D-4491-A832-97E83F23A224Q34568640-FB96BEE3-CAD7-4AA0-93E2-0D855152F702Q34579250-432B4F2A-BB84-43DB-BA64-239198C07057Q34639791-C8DD7A19-3CA6-44B9-A598-E30C4F944FB7Q34647525-43FA2EEE-3420-42A2-8721-1ECE99A9DCCCQ34674369-7B9C5D26-A990-41B4-B1BF-6AE794772274Q34746400-A898CF73-40C6-4D36-9CB5-998AB654DEA0Q34796372-F09ED7EE-C163-4D99-81A3-0A422561CC82Q34898802-16633E2F-E8B7-4F50-A1FF-0517A7D4DF13Q34959995-ACE17580-DCD4-4924-8E69-7FD145512071Q34992760-37160CA2-3C2B-4D0B-9D02-D8F92B887685Q35041547-40D1CD99-9AFB-4894-88B8-BE08ED6DFAFD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Gregory J. Kato
@ast
Gregory J. Kato
@en
Gregory J. Kato
@es
Gregory J. Kato
@nl
Gregory J. Kato
@sl
type
label
Gregory J. Kato
@ast
Gregory J. Kato
@en
Gregory J. Kato
@es
Gregory J. Kato
@nl
Gregory J. Kato
@sl
altLabel
G Kato Gregory Kato, Greg Kato, GJ Kato
@en
prefLabel
Gregory J. Kato
@ast
Gregory J. Kato
@en
Gregory J. Kato
@es
Gregory J. Kato
@nl
Gregory J. Kato
@sl
P108
P214
P244
P1053
I-7615-2014
P106
P108
P1153
26642874900
P2038
Gregory_Kato
P21
P213
0000 0003 5337 1174
P214
P244
n2012185388
P31
P3829
P3835
gregory-kato
P496
0000-0003-4465-3217
P735
P7859
lccn-n2012185388